Table of Contents

2019-2024 Global Inhaled Nitric Oxide Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Inhaled Nitric Oxide Consumption 2014-2024
  • 2.1.2 Inhaled Nitric Oxide Consumption CAGR by Region
• 2.2 Inhaled Nitric Oxide Segment by Type
  • 2.2.1 99.92% Purity
  • 2.2.2 99.99% Purity
  • 2.2.3 Other
• 2.3 Inhaled Nitric Oxide Consumption by Type
  • 2.3.1 Global Inhaled Nitric Oxide Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Inhaled Nitric Oxide Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Inhaled Nitric Oxide Sale Price by Type (2014-2019)
• 2.4 Inhaled Nitric Oxide Segment by Application
  • 2.4.1 ARDS
  • 2.4.2 PPHN
  • 2.4.3 Other Diseases
• 2.5 Inhaled Nitric Oxide Consumption by Application
  • 2.5.1 Global Inhaled Nitric Oxide Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Inhaled Nitric Oxide Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Inhaled Nitric Oxide Sale Price by Application (2014-2019)

3 Global Inhaled Nitric Oxide by Players

• 3.1 Global Inhaled Nitric Oxide Sales Market Share by Players
  • 3.1.1 Global Inhaled Nitric Oxide Sales by Players (2017-2019)
  • 3.1.2 Global Inhaled Nitric Oxide Sales Market Share by Players (2017-2019)
• 3.2 Global Inhaled Nitric Oxide Revenue Market Share by Players
  • 3.2.1 Global Inhaled Nitric Oxide Revenue by Players (2017-2019)
  • 3.2.2 Global Inhaled Nitric Oxide Revenue Market Share by Players (2017-2019)
• 3.3 Global Inhaled Nitric Oxide Sale Price by Players
• 3.4 Global Inhaled Nitric Oxide Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Inhaled Nitric Oxide Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Inhaled Nitric Oxide Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Inhaled Nitric Oxide by Regions

• 4.1 Inhaled Nitric Oxide by Regions
  • 4.1.1 Global Inhaled Nitric Oxide Consumption by Regions
  • 4.1.2 Global Inhaled Nitric Oxide Value by Regions
• 4.2 Americas Inhaled Nitric Oxide Consumption Growth
• 4.3 APAC Inhaled Nitric Oxide Consumption Growth
• 4.4 Europe Inhaled Nitric Oxide Consumption Growth
• 4.5 Middle East & Africa Inhaled Nitric Oxide Consumption Growth

5 Americas

• 5.1 Americas Inhaled Nitric Oxide Consumption by Countries
  • 5.1.1 Americas Inhaled Nitric Oxide Consumption by Countries (2014-2019)
  • 5.1.2 Americas Inhaled Nitric Oxide Value by Countries (2014-2019)
• 5.2 Americas Inhaled Nitric Oxide Consumption by Type
• 5.3 Americas Inhaled Nitric Oxide Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Inhaled Nitric Oxide Consumption by Countries
  • 6.1.1 APAC Inhaled Nitric Oxide Consumption by Countries (2014-2019)
  • 6.1.2 APAC Inhaled Nitric Oxide Value by Countries (2014-2019)
• 6.2 APAC Inhaled Nitric Oxide Consumption by Type
• 6.3 APAC Inhaled Nitric Oxide Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Inhaled Nitric Oxide by Countries
  • 7.1.1 Europe Inhaled Nitric Oxide Consumption by Countries (2014-2019)
  • 7.1.2 Europe Inhaled Nitric Oxide Value by Countries (2014-2019)
• 7.2 Europe Inhaled Nitric Oxide Consumption by Type
• 7.3 Europe Inhaled Nitric Oxide Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Inhaled Nitric Oxide by Countries
  • 8.1.1 Middle East & Africa Inhaled Nitric Oxide Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Inhaled Nitric Oxide Value by Countries (2014-2019)
• 8.2 Middle East & Africa Inhaled Nitric Oxide Consumption by Type
• 8.3 Middle East & Africa Inhaled Nitric Oxide Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Inhaled Nitric Oxide Distributors
• 10.3 Inhaled Nitric Oxide Customer

11 Global Inhaled Nitric Oxide Market Forecast

• 11.1 Global Inhaled Nitric Oxide Consumption Forecast (2019-2024)
• 11.2 Global Inhaled Nitric Oxide Forecast by Regions
  • 11.2.1 Global Inhaled Nitric Oxide Forecast by Regions (2019-2024)
  • 11.2.2 Global Inhaled Nitric Oxide Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Inhaled Nitric Oxide Forecast by Type
• 11.8 Global Inhaled Nitric Oxide Forecast by Application

12 Key Players Analysis

• 12.1 Mallinckrodt
  • 12.1.1 Company Details
  • 12.1.2 Inhaled Nitric Oxide Product Offered
  • 12.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Mallinckrodt News
• 12.2 Praxair
  • 12.2.1 Company Details
  • 12.2.2 Inhaled Nitric Oxide Product Offered
  • 12.2.3 Praxair Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Praxair News
• 12.3 Air Liquide
  • 12.3.1 Company Details
  • 12.3.2 Inhaled Nitric Oxide Product Offered
  • 12.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Air Liquide News

...

13 Research Findings and Conclusion

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.
According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.
Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

According to this study, over the next five years the Inhaled Nitric Oxide market will register a 7.9% CAGR in terms of revenue, the global market size will reach US$ 1240 million by 2024, from US$ 780 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Inhaled Nitric Oxide business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Nitric Oxide market by product type, application, key manufacturers and key regions and countries.

This study considers the Inhaled Nitric Oxide value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
99.92% Purity
99.99% Purity
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
ARDS
PPHN
Other Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mallinckrodt
Praxair
Air Liquide
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Inhaled Nitric Oxide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Inhaled Nitric Oxide market by identifying its various subsegments.
Focuses on the key global Inhaled Nitric Oxide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Inhaled Nitric Oxide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Inhaled Nitric Oxide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.